% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@PHDTHESIS{Lambertz:782556,
author = {Lambertz, Jessica},
othercontributors = {Weiskirchen, Ralf and Hollert, Henner and van Dongen, Joost
Thomas},
title = {{L}ipocalin 2 in perpetuating hepatic lipid homeostasis
challenged by high fructose diet},
school = {RWTH Aachen University},
type = {Dissertation},
address = {Aachen},
reportid = {RWTH-2020-01951},
pages = {1 Online-Ressource (123 Seiten) : Illustrationen,
Diagramme},
year = {2019},
note = {Veröffentlicht auf dem Publikationsserver der RWTH Aachen
University 2020; Dissertation, RWTH Aachen University, 2019},
abstract = {Fructose is known as a lipogenic sugar, part of High
Fructose Corn Syrup (HFCS) contributing to elevated fasting
plasma free fatty acids and plasma triglycerides, redounding
to the development of metabolic disturbances and diabetes.
About $90\%$ of ingested fructose is metabolized in the
liver. Chronic fructose consumption can promote hepatic
lipid synthesis and triosephosphate can provide further
substrates for de novo lipogenesis. Furthermore, fructose
was shown to be involved in the development and worsening of
kidney damage going along with systemic inflammation,
tubular injury and renal dysfunction. The intake of excess
dietary fructose most often leads to non-alcoholic fatty
liver disease (NAFLD). Regarding the development of NAFLD
with the “two-hit theory”, steatosis is the first hit
and steatohepatitis, which requires the presence of factors
such as oxidative stress, characterizes the second hit.
Chronic consumption of fructose results in lipogenic gene
expression in this organ. Nevertheless, how fructose is
involved in NAFLD progression is still not fully understood,
limiting therapy. Lipocalin 2 (LCN2) is a small secreted
transport protein that binds to fatty acids, phospholipids,
steroids, retinol, and pheromones. LCN2 regulates lipid and
energy metabolism in obesity and is upregulated in response
to insulin. It was previously discovered that LCN2 has
hepatoprotective effects and upregulation is a reliable
marker of liver damage and inflammation. To investigate if
LCN2 has impact on the metabolism of fructose and thereby
arising liver and kidney damage, we fed wild type and
Lcn2-deficient mice for 4 and 8 weeks on diets that were
enriched in fructose either by adding this sugar to the
drinking water $(30\%$ (w/v)), or by feeding a chow
containing $60\%$ (w/w) fructose. Feeding high fructose was
hypothesized to cause time-depended liver- and kidney damage
in mice and more severe steatosis in mice lacking LCN2 after
prolonged feeding of fructose was expected. In this study,
male and female mice were analysed separately in order to
investigate gender-specific differences during progression
of disease. Body weight and daily intake of food and water
of these mice was measured regularly during the study. Fat
content in liver sections was visualized using Oil Red
O-stain, and expression levels of genes involved in fat and
sugar metabolism, as well as inflammatory marker genes were
measured by qRT-PCR and Western blot analysis.
Fructose-induced steatosis and liver damage was more
prominent in female than in male mice, but the most severe
hepatic damage occurred in female mice lacking LCN2. Slight
kidney damage was only observed in Lcn2-deficient mice.
Unexpectedly, consumption of elevated fructose did not
induce de novo lipogenesis or inflammation. Instead,
fructose appears to directly affect liver homeostasis,
thereby manipulating fat metabolism. In conclusion, this
study shows that LCN2 acts in a lipid-independent manner to
protect the liver against fructose-induced damage. Female
mice showed higher steatosis and damage after fructose
treatment than their male counterparts, confirming the
potential influence of estrogen on lipid homeostasis
reported in previous studies. Fructose might disturb liver
homeostasis by promoting lipid uptake into the liver, while
LCN2 counteracts this lipid uptake.},
cin = {526000-3 / 163720 / 160000},
ddc = {570},
cid = {$I:(DE-82)526000-3_20140620$ / $I:(DE-82)163720_20140620$ /
$I:(DE-82)160000_20140620$},
typ = {PUB:(DE-HGF)11},
doi = {10.18154/RWTH-2020-01951},
url = {https://publications.rwth-aachen.de/record/782556},
}